3 Dividend Stocks Fighting for Growth

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 14 June, 2014 by The TZ Newswire Staff

3 Dividend Stocks Fighting for Growth

Johnson & Johnson (JNJ), Merck (MRK), and Pfizer (PFE) are spending billions developing new drugs. Here’s what you need to know about therapies closest to winning market approval.

See also
- Next Article The Wall Street Journal: Ukraine, Russia, EU in last-ditch talks on gas prices
- Previous Article Will a New War in Iraq Cause Oil Prices to Soar?
Editorial Calender

June 2014

M T W T F S S

1

2 3 4 5 6 7 8

9 10 11 12 13 14 15

16 17 18 19 20 21 22

23 24 25 26 27 28 29

30

« May Jul »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 14 June, 2014 by The TZ Newswire Staff

3 Dividend Stocks Fighting for Growth

See also

Editorial Calender

Recent Tags